Literature DB >> 27155218

Preeclampsia and the Risk of Future Vascular Disease and Mortality: A Review.

Mayri Sagady Leslie, Linda A Briggs.   

Abstract

INTRODUCTION: Preeclampsia increases a woman's long-term risk of vascular disease and/or death including chronic hypertension, myocardial infarction, heart failure, stroke, and venous thromboembolism. The literature suggests that maternity care providers may be unaware of this association.
METHODS: A database search was conducted examining the long-term effects of hypertensive disorders of pregnancy using MEDLINE, Scopus, CINAHL, ISI Web of Knowledge, and the Cochrane Database of Systematic Reviews. Inclusion criteria were: 1) English language, 2) peer-reviewed journals, 3) January 2000 to July 2015, 4) systematic reviews with or without meta-analyses, and 5) studies that addressed the relationship between hypertensive disorders of pregnancy and vascular disease such as hypertension, cardiovascular disease (CVD), and cerebrovascular diseases.
RESULTS: Three systematic reviews with meta-analysis qualified for this review. They represented 48 unique studies from 20 countries and included a total of 3,598,601 women. Preeclampsia was associated with a 3-fold increased risk for developing chronic hypertension. Compared with normotensive women, those with preeclampsia experienced double the risk, or more, for CVD or CVD-related mortality. Preeclampsia was also associated with approximately double the risk for fatal or nonfatal stroke. DISCUSSION: Preeclampsia is associated with an increased risk for future chronic hypertension, CVD, cerebrovascular disease, and death. While evidence shows that women with cardiac risk factors may have a higher chance of developing preeclampsia, many women with preeclampsia have no CVD risk factors. Measures to prevent preeclampsia such as calcium supplementation for women with low calcium intake and low-dose aspirin for women with a history of more than one incident of preeclampsia or a preterm birth associated with preeclampsia are supported by evidence. Reduction of modifiable risks associated with CVD before, during, and after pregnancy is recommended. All care providers and women should be educated regarding these risks and the importance of pregnancy history to future health.
© 2016 by the American College of Nurse-Midwives.

Entities:  

Keywords:  obstetric complications; patient education; postpartum care; preventative health care; primary care; systematic reviews and meta-analyses

Mesh:

Year:  2016        PMID: 27155218     DOI: 10.1111/jmwh.12469

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  19 in total

1.  Overexpression of tissue factor pathway inhibitor 2 attenuates trophoblast proliferation and invasion in preeclampsia.

Authors:  Lili Zheng; Jing Huang; Yuan Su; Fang Wang; Hongfang Kong; Hong Xin
Journal:  Hum Cell       Date:  2020-03-04       Impact factor: 4.174

2.  Nesfatin-1 Promotes Proliferation, Migration and Invasion of HTR-8/SVneo Trophoblast Cells and Inhibits Oxidative Stress via Activation of PI3K/AKT/mTOR and AKT/GSK3β Pathway.

Authors:  Tingting Li; Sumei Wei; Conghong Fan; Dongmei Tang; Dan Luo
Journal:  Reprod Sci       Date:  2020-09-24       Impact factor: 3.060

3.  The Association of Adverse Pregnancy Outcomes and Cardiovascular Disease: Current Knowledge and Future Directions.

Authors:  Anum S Minhas; Wendy Ying; S Michelle Ogunwole; Michael Miller; Sammy Zakaria; Arthur J Vaught; Allison G Hays; Andreea A Creanga; Ari Cedars; Erin D Michos; Roger S Blumenthal; Garima Sharma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-10-31

Review 4.  REPRODUCTIVE TOXICOLOGY: Pregnancy exposure to endocrine disrupting chemicals: implications for women's health.

Authors:  Diana K Haggerty; Kristen Upson; Diana C Pacyga; J Ebba Franko; Joseph M Braun; Rita S Strakovsky
Journal:  Reproduction       Date:  2021-10-07       Impact factor: 3.923

5.  Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women.

Authors:  Mildren A Del-Sueldo; María A Mendonça-Rivera; Martha B Sánchez-Zambrano; Judith Zilberman; Ana G Múnera-Echeverri; María Paniagua; Lourdes Campos-Alcántara; Claudia Almonte; Amalia Paix-Gonzales; Claudia V Anchique-Santos; Claudine J Coronel; Gabriela Castillo; María G Parra-Machuca; Ivanna Duro; Paola Varletta; Patricia Delgado; Verónica I Volberg; Adriana C Puente-Barragán; Adriana Rodríguez; Aida Rotta-Rotta; Anabela Fernández; Ana C Izeta-Gutiérrez; Ana E Ancona-Vadillo; Analía Aquieri; Andrea Corrales; Andrea Simeone; Bibiana Rubilar; Carolina Artucio; Carolina Pimentel-Fernández; Celi Marques-Santos; Clara Saldarriaga; Christian Chávez; Cristina Cáceres; Dahiana Ibarrola; Daniela Barranco; Edison Muñoz-Ortiz; Edith D Ruiz-Gastelum; Eduardo Bianco; Elena Murguía; Enrique Soto; Fabiola Rodríguez-Caballero; Fanny Otiniano-Costa; Giovanna Valentino; Iris B Rodríguez-Cermeño; Ivan R Rivera; Jairo A Gándara-Ricardo; Jesús A Velásquez-Penagos; Judith Torales; Karina Scavenius; Karen Dueñas-Criado; Laura García; Laura Roballo; Lucía R Kazelian; Macarena Coussirat-Liendo; María C Costa-Almeida; Mariana Drever; Mariela Lujambio; Marildes L Castro; Maritza Rodríguez-Sifuentes; Mónica Acevedo; Mónica Giambruno; Mónica Ramírez; Nancy Gómez; Narcisa Gutiérrez-Castillo; Onelia Greatty; Paola Harwicz; Patricia Notaro; Rocío Falcón; Rosario López; Sady Montefilpo; Sara Ramírez-Flores; Silvina Verdugo; Soledad Murguía; Sonia Constantini; Thais C Vieira; Virginia Michelis; César M Serra
Journal:  Arch Cardiol Mex       Date:  2022

Review 6.  Preeclampsia and Cerebrovascular Disease.

Authors:  Eliza C Miller
Journal:  Hypertension       Date:  2019-05-06       Impact factor: 10.190

7.  Exposure to Endocrine-Disrupting Chemicals During Pregnancy Is Associated with Weight Change Through 1 Year Postpartum Among Women in the Early-Life Exposure in Mexico to Environmental Toxicants Project.

Authors:  Wei Perng; Nicole M Kasper; Deborah J Watkins; Brisa N Sanchez; John D Meeker; Alejandra Cantoral; Maritsa Solano-González; Martha Maria Tellez-Rojo; Karen Peterson
Journal:  J Womens Health (Larchmt)       Date:  2020-04-01       Impact factor: 2.681

Review 8.  Pre-eclampsia: pathogenesis, novel diagnostics and therapies.

Authors:  Elizabeth A Phipps; Ravi Thadhani; Thomas Benzing; S Ananth Karumanchi
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

Review 9.  Gender, aging and longevity in humans: an update of an intriguing/neglected scenario paving the way to a gender-specific medicine.

Authors:  Rita Ostan; Daniela Monti; Paola Gueresi; Mauro Bussolotto; Claudio Franceschi; Giovannella Baggio
Journal:  Clin Sci (Lond)       Date:  2016-10-01       Impact factor: 6.124

10.  Maternal Cardiovascular and Cerebrovascular Health After Placental Abruption: A Systematic Review and Meta-Analysis (CHAP-SR).

Authors:  Cande V Ananth; Haylea S Patrick; Srinidhi Ananth; Yingting Zhang; William J Kostis; Meike Schuster
Journal:  Am J Epidemiol       Date:  2021-12-01       Impact factor: 5.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.